Frank Perabo
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 29
-
- Epigenetics and DNA Methylation 11
- Co-authors
- Stefan C. Müller (18 shared papers)Peter Albers (9 shared papers)Jörg Ellinger (9 shared papers)Patrick J. Bastian (9 shared papers)Alexander von Ruecker (10 shared papers)Stefan C. Mueller (7 shared papers)Doris Schmidt (12 shared papers)Andreas Wirger (10 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)The Journal of Urology (7 papers)Annals of Oncology (6 papers)Urology (3 papers)European Urology (2 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Frank Perabo
70 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 305
- Pulmonary and Respiratory Medicine 559
- Drug Discovery 2
- Urology 63
- Surgery 351
Countries citing papers authored by Frank Perabo
This map shows the geographic impact of Frank Perabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Perabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Perabo more than expected).
Fields of papers citing papers by Frank Perabo
This network shows the impact of papers produced by Frank Perabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Perabo. The network helps show where Frank Perabo may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Perabo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 140 | |
| 2 | 2007 | 101 | |
| 3 | 2008 | 85 | |
| 4 | 2002 | 76 | |
| 5 | 2009 | 74 | |
| 6 | 2014 | 71 | |
| 7 | 2002 | 70 | |
| 8 | 2007 | 67 | |
| 9 | 2016 | 66 | |
| 10 | 2016 | 63 | |
| 11 | 2008 | 58 | |
| 12 | Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. | 2007 | 38 |
| 13 | Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. | 2006 | 36 |
| 14 | 2015 | 34 | |
| 15 | Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. | 2006 | 32 |
| 16 | 2005 | 30 | |
| 17 | 2001 | 29 | |
| 18 | 2014 | 29 | |
| 19 | 2021 | 27 | |
| 20 | Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. | 2004 | 27 |
About Frank Perabo
Frank Perabo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 73 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Epigenetics and DNA Methylation (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Cancer, Lipids, and Metabolism (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Genomics and Diagnostics (5 papers) and Testicular diseases and treatments (4 papers). The work is most often cited by research in Cancer Research (305 citations), Pulmonary and Respiratory Medicine (559 citations), Drug Discovery (2 citations), Urology (63 citations) and Surgery (351 citations). Frank Perabo has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Stefan C. Müller, Peter Albers, Jörg Ellinger, Patrick J. Bastian, Alexander von Ruecker, Stefan C. Mueller, Doris Schmidt, Andreas Wirger, Alexander von Rücker and Bertrand Tombal. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Annals of Oncology, Urology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.